Related Experiment Video
Updated: Jul 12, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach
Genaro Gabriel Ortiz1,2, Javier Ramírez-Jirano3, Raul L Arizaga4
1Department of Philosophical and Methodological Disciplines, University Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Frontotemporal lobar degeneration (FTLD) and Limbic age-related encephalopathy (LATE) are complex neurodegenerative diseases. Emerging research reveals a potential overlap in their pathology, particularly involving TDP-43 protein, and highlights the critical role of genetics in both conditions.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Frontotemporal lobar degeneration (FTLD) is a leading cause of dementia in individuals under 65.
- Frontotemporal-TDP, a subtype of FTLD, involves TDP-43 protein aggregation in the brain, causing neuronal degeneration and cognitive decline.
- Limbic age-related encephalopathy (LATE) affects the limbic system, impacting memory and emotions, and may share pathogenic pathways with FTLD.
Purpose of the Study:
- To explore the potential overlap in pathogenic processes between FTLD and LATE.
- To investigate the role of transactive response DNA-binding protein 43 (TDP-43) pathology in LATE.
- To understand the genetic factors contributing to both FTLD and LATE.
Main Methods:
- Review of emerging research on FTLD and LATE.
- Analysis of studies investigating TDP-43 protein aggregation.
- Examination of genetic mutations and variants associated with these neurodegenerative diseases.
Main Results:
- Evidence suggests a potential overlap in the underlying pathology of FTLD and LATE, with TDP-43 pathology observed in some LATE cases.
- Genetic factors, including mutations in GRN and C9orf72, are implicated in FTLD.
- Specific genetic variants are associated with an increased risk of LATE.
Conclusions:
- Understanding the shared TDP-43 pathology and genetic links between FTLD and LATE is crucial.
- These insights can inform the development of targeted therapeutic strategies for both conditions.
- Further research into the genetic underpinnings of these neurodegenerative diseases is warranted.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
08:33Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Dementia
The progression of dementia is generally gradual....